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• Prenatal diagnosis and TOP at an early gestation may reduce maternal morbidities and improve the outcome. 
• This can be done by carrying out routine anomaly scan at 18+0 to 20+6 weeks of pregnancy with its detection rate of 83%.3 
• In some cases, combined anomaly scan and genetic study will further increase the diagnostic accuracy. 
Conclusions 
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• The widespread use and advance development in prenatal screening had 
resulted in increasing number of lethal congenital fetal anomalies 
diagnosed during pregnancy. 
• Therapeutic options are limited and these parents will have to decide 
whether they will continue or terminate the pregnancy.1 
• However, either termination or continuation of pregnancy will give rise 
to associated maternal morbidities that might bring more traumas to the 
vulnerable mothers. 
• The purpose of this study was to determine maternal morbidities in 
relation to prenatal diagnosis of lethal fetal anomalies and termination of 
pregnancy (TOP).  
  
 
 
 
 
 
 
 
• This was a retrospective review in Hospital Tengku Ampuan Afzan, 
Kuantan, Malaysia in the year of 2011. All patients diagnosed prenatally 
to carry lethal fetal anomalies was reviewed.  
• The outcome of the pregnancy including type of labour, mode of 
induction and delivery, and associated morbidities during antenatal, 
intrapartum, and postpartum period was analysed. 
• TOP for fetal lethal anomalies were decided based on Section 312 of the 
Penal Code (Laws of Malaysia) that a termination of pregnancy is 
permitted in circumstances where there is risk to the life of the pregnant 
woman or threat of injury to her physical or mental health.2 
• Analysis was done by using SPSS version 18.0. 
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Table II. Reasons of patients did not undergo genetic study 
Reasons n=18 
Ultrasound alone had confirmed fetal  
abnormalities that were incompatible with life 
9 (50.0) 
Couple refused for prenatal diagnostic  
Procedure 
1 (5.6) 
Patients developed intrauterine death 5 (27.8) 
Patients developed spontaneous labour 3 (16.6) 
Data are expressed as n (%) 
Table III. Reasons of rehospitalisation 
Reasons n=7 
Patients developed antenatal morbidity 4 (53.1) 
Readmission for repeated course of medical  
Termination 
3 (46.9) 
Data are expressed as n (%) 
Table I. Demographic characteristics of the study samples 
Characteristics n=25 
Maternal age (years) *29.9±6.3 
Gravidity *3.0±2.1 
Parity *1.8±1.8 
Race 
 Malay 
 Chinese 
 Indian 
 Others 
 Foreigner 
 
†19 (76.0) 
†0 (0.0) 
†0 (0.0) 
†3 (12.0) 
†3 (12.0) 
Antenatal profile 
 Age > 35 years old 
 Diabetes Mellitus 
 Previous history of unexplained IUD 
 Previous pregnancy with fetal congenital anomaly 
 Previous scar 
 Grandmultipara 
 
†6 (24.0) 
†6 (24.0) 
†1 (4.0) 
†0 (0.0) 
†4 (16.0) 
†2 (8.0) 
Gestational age at diagnosis of lethal fetal anomalies (weeks) *26.5±7.4 
Gestational age at TOP or delivery (weeks) *28.7±7.8 
Genetic study 
 Yes 
 No 
Type of fetal lethal anomalies 
 Fetuses with multiple structural abnormalities 
 Anencephaly or severe encephalocele 
 Non-immune hydrops fetalis 
 Syndromic fetuses 
 
†7 (28.0) 
†18 (72.0) 
 
†10 (40.0) 
†8 (32.0) 
†4 (16.0) 
†3 (12.0) 
*mean±SD †n (%) 
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Figure 2. Adverse events in relation to prenatal diagnosis of lethal fetal anomalies 
and termination of pregnancy 
n = 25 
• Twenty five pregnant patients were diagnosed with lethal fetal anomalies via 
ultrasound with or without genetic study.  
• Table I presents the demographic characteristics of the study samples. 
• The types of lethal fetal anomalies are as shown in Table I. The syndromic 
fetuses comprises of 2 cases of Pentalogy of Cantrell and 1 case of Edward’s 
syndrome. 
• Only 7 (28.0%) patients underwent genetic study (i.e. 3 with amniocentesis, 3 
with cordocentesis, and 1 with chorion villus sampling) to investigate for 
aneuploidy. The remaining 18 (72.0%) patients did not undergo genetic study 
with the reasons as mentioned in Table II. 
• Seven (28%) patients had early counseling and TOP at the gestation of < 22 
weeks. Beyond 22 weeks gestation, 8 (32%) had TOP and 10 (40%) had 
spontaneous delivery. Figure 1 shows the mode of delivery of the study samples. 
The abdominal deliveries were for transverse lie in labour and emergency 
hysterotomy for failed induction complicated by hysterectomy due to 
intraoperative finding of ruptured uterus. 
• Figure 2 shows the adverse events in relation to prenatal diagnosis of lethal fetal 
anomalies and termination of pregnancy. One patient with gestational 
hypertension developed impending eclampsia requiring intravenous MgSO4 
infusion at the gestational age of 35 weeks. 
• Mean duration of hospital stay was 6.6±3.7 days. Seven patients (28.0%) 
required rehospitalisation with the reasons as mentioned in Table III. 
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Figure 1. Mode of delivery among the study samples 
n = 25 
Results 
• The gestational age at confirmed diagnosis of fetal lethal anomaly was relatively late (i.e. 26.5±7.4 weeks), leading to late counseling and TOP. Early 
diagnosis has potential benefits as termination is safer the earlier it is performed. Risk of termination increase with gestational age. Complication rates 
increase from 5/1000 medical procedures at 10-12 weeks to 16/1000 at 20 weeks of gestation and over.3 Similarly, in this study, adverse events of retained 
placenta, endometritis, and uterine rupture occurred among patients with TOP at 21 – 24 weeks gestation. 
• In Byrne and Morrison’s study with 13 cases of lethal fetal abnormality, there were 4 cases of IUD, 4 cases of preterm complications (e.g. preterm premature 
ruptures of membranes, preterm labour, placental abruption, coagulopathy, and severe pre-eclampsia) and 1 case of caesarean section for malpresentation.4 In 
Saudi Arabia, lethal congenital anomalies were considered to be the prime factor responsible for 25% of their stillbirths.5 Our study showed similar outcome. 
• In a study regarding polyhydramnios, congenital anomaly seen in 31.7% cases.6 Our study recorded 4 cases of severe polyhydramnios and all of them 
required amnioreduction. Study showed that it is the underlying cause (congenital malformation) of polyhydramnios rather than the polyhydramnios itself 
responsible for 39% of premature labour.7 Among the 4 cases of polyhydramnios in our study, 3 of them had preterm delivery. 
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